These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1822791)

  • 1. Type III glycogen storage disease: an adult case with mild disease but complete absence of debrancher protein.
    Yang BZ; Stewart C; Ding JH; Chen YT
    Neuromuscul Disord; 1991; 1(3):173-6. PubMed ID: 1822791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease.
    Chen YT; He JK; Ding JH; Brown BI
    Am J Hum Genet; 1987 Dec; 41(6):1002-15. PubMed ID: 2961257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.
    Coleman RA; Winter HS; Wolf B; Gilchrist JM; Chen YT
    Ann Intern Med; 1992 Jun; 116(11):896-900. PubMed ID: 1580445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III.
    Ding JH; de Barsy T; Brown BI; Coleman RA; Chen YT
    J Pediatr; 1990 Jan; 116(1):95-100. PubMed ID: 2295969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Debrancher deficiency: neuromuscular disorder in 5 adults.
    DiMauro S; Hartwig GB; Hays A; Eastwood AB; Franco R; Olarte M; Chang M; Roses AD; Fetell M; Schoenfeldt RS; Stern LZ
    Ann Neurol; 1979 May; 5(5):422-36. PubMed ID: 288318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some properties of fibroblasts from a patient with debrancher deficiency.
    Furutani A; Yano O; Gotoh S; Higashi K; Hasegawa E; Ohnishi A
    J UOEH; 1990 Dec; 12(4):411-8. PubMed ID: 2287841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nine cases of debrancher deficiency (glycogen storage disease type III) presenting muscle weakness--study on clinicobiochemical analysis].
    Fukuda T; Sugie H; Ito M; Tsurui S; Sugie Y; Igarashi Y
    Rinsho Shinkeigaku; 1996 Apr; 36(4):540-3. PubMed ID: 8810846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].
    Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutation analysis of glycogen debrancher enzyme gene in five Chinese patients with glycogen storage disease type III].
    Zhuang TF; Qiu ZQ; Wei M; Huang SZ
    Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):85-8. PubMed ID: 15833157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse model of glycogen storage disease type III.
    Liu KM; Wu JY; Chen YT
    Mol Genet Metab; 2014 Apr; 111(4):467-76. PubMed ID: 24613482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12-->G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb.
    Okubo M; Horinishi A; Nakamura N; Aoyama Y; Hashimoto M; Endo Y; Murase T
    Hum Genet; 1998 Jan; 102(1):1-5. PubMed ID: 9490286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet therapy in severe clinical expression of debrancher deficiency.
    Azael Meza A; Ayub M; Cantú JM; Flores J
    Arch Invest Med (Mex); 1991; 22(3-4):285-8. PubMed ID: 1844114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.
    Oh SH; Park HD; Ki CS; Choe YH; Lee SY
    Clin Chem Lab Med; 2008; 46(9):1245-9. PubMed ID: 18785866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen storage disease type III in the Irish population.
    Crushell E; Treacy EP; Dawe J; Durkie M; Beauchamp NJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S215-8. PubMed ID: 20490926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debrancher enzyme activity in blood cells of families with type III glycogen storage disease. A method for diagnosis of heterozygotes.
    Chayoth R; Moses SW; Steinitz K
    Isr J Med Sci; 1967; 3(3):422-6. PubMed ID: 5317552
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathological characteristics of glycogen storage disease III in skeletal muscle.
    Gershen LD; Prayson BE; Prayson RA
    J Clin Neurosci; 2015 Oct; 22(10):1674-5. PubMed ID: 26067541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency.
    Lucchiari S; Santoro D; Pagliarani S; Comi GP
    Acta Myol; 2007 Jul; 26(1):72-4. PubMed ID: 17915576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive prenatal diagnosis for type III glycogen storage disease.
    Yang BZ; Ding JH; Brown BI; Chen YT
    Am J Hum Genet; 1990 Oct; 47(4):735-9. PubMed ID: 2220811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.
    Lucchiari S; Fogh I; Prelle A; Parini R; Bresolin N; Melis D; Fiori L; Scarlato G; Comi GP
    Am J Med Genet; 2002 May; 109(3):183-90. PubMed ID: 11977176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some cases of Type III glycogen storage disease.
    Rosenfield EL; Popova IA; Chibisov IV
    Clin Chim Acta; 1976 Mar; 67(2):123-30. PubMed ID: 1061645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.